- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 30, 2025 | 324.17M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 312.17M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 307.86M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 232.4M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 231.22M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $542.72M |
| Capex | Q3 2025 · Sep 30, 2024 | $592.21M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$2.02B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$1.49B |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $2.04B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $2B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $313.32M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $126.42M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $701.91M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $2.42B |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $1.64B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.61B |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.8B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $2.41B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $3.87B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $2.68B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $3.52B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $4.85B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $2.1B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.17B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $5.1B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $4.48B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $3.8B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $4.87B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $8.82B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $9.65B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$3.31 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$8.50 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$4.09 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$10.49 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$3.31 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$8.15 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$4.09 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$10.49 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $283.1M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $752.13M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $233.59M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $657.06M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $325.31M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $850.39M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $324.37M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $896.17M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$978.43M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.88B |
| Net Income | Q3 2025 · Sep 30, 2024 | −$992.48M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$2.32B |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$942.02M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$2.44B |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$770.54M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$2.29B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $670.2M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.67B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $412.54M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.29B |
| Revenue | Q3 2025 · Sep 30, 2025 | $336.58M |
| Revenue | Q3 2025 · Sep 30, 2025 | $831.06M |
| Revenue | Q3 2025 · Sep 30, 2024 | $200.04M |
| Revenue | Q3 2025 · Sep 30, 2024 | $573.36M |